These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 6271703

  • 1. Immunology of pyelonephritis in the primate model. II. Effect on immunosuppression.
    Roberts JA, Domingue GJ, Martin LN, Kim JC, Rangan SR.
    Invest Urol; 1981 Nov; 19(3):148-53. PubMed ID: 6271703
    [Abstract] [Full Text] [Related]

  • 2. Immunological enhancement in the pathogenesis of pyelonephritis.
    Miller TE, Burnham S, North JD.
    Clin Exp Immunol; 1976 May; 24(2):336-45. PubMed ID: 776466
    [Abstract] [Full Text] [Related]

  • 3. Immunology of pyelonephritis in the primate model: live versus heat-killed bacteria.
    Roberts JA, Domingue GJ, Martin LN, Kim JC.
    Kidney Int; 1981 Feb; 19(2):297-305. PubMed ID: 7014985
    [Abstract] [Full Text] [Related]

  • 4. [Modification by cyclophosphamide of the effect of autovaccination in chronic pyelonephritis in an animal experiment].
    Straube E, Broschewitz U, Nimmich W, Naumann G, Hacker K.
    Z Urol Nephrol; 1987 Jun; 80(6):353-63. PubMed ID: 3307215
    [Abstract] [Full Text] [Related]

  • 5. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression.
    Ahlstedt S.
    Scand J Infect Dis Suppl; 1980 Jun; Suppl 24():216-9. PubMed ID: 7010558
    [Abstract] [Full Text] [Related]

  • 6. [Autovaccination in chronic pyelonephritis in the animal experiment--effect of cyclophosphamide on splenic and thymus lymphocytes].
    Straube E, Schütt W.
    Z Urol Nephrol; 1987 Aug; 80(8):483-90. PubMed ID: 3318218
    [Abstract] [Full Text] [Related]

  • 7. Chronic pyelonephritis: modulation of host defenses by cyclosporin A.
    Findon G, Miller TE.
    J Lab Clin Med; 1989 Aug; 114(2):157-64. PubMed ID: 2666534
    [Abstract] [Full Text] [Related]

  • 8. Experimentally induced chronic pyelonephritis using bacterial antigen and its prevention with immunosuppression.
    Strong DW, Lawson RK, Hodges CV.
    Invest Urol; 1974 May; 11(6):479-85. PubMed ID: 4597433
    [No Abstract] [Full Text] [Related]

  • 9. Comparative study of cyclophosphamide, 6-mercaptopurine, azathiopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse.
    Otterness IG, Chang YH.
    Clin Exp Immunol; 1976 Nov; 26(2):346-54. PubMed ID: 991462
    [Abstract] [Full Text] [Related]

  • 10. Experimental pyelonephritis in the monkey. II. The prognostic value of radionuclide evaluation of the urinary tract.
    Roberts JA, Domingue GJ.
    Invest Urol; 1975 Mar; 12(5):374-80. PubMed ID: 1089612
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive treatment of experimental pyelonephritis with a combination of oxytetracycline and azathioprine.
    Hagemann I, Philipp H, Briedigkeit H, Dutz H.
    Clin Nephrol; 1973 Mar; 1(6):372-6. PubMed ID: 4594998
    [No Abstract] [Full Text] [Related]

  • 12. Chronic pyelonephritis. Electron microscopic study. II. Persistence of variant bacterial forms.
    Smith TW, Roberts JA.
    Invest Urol; 1978 Sep; 16(2):154-62. PubMed ID: 361629
    [Abstract] [Full Text] [Related]

  • 13. [Effect of cyclophosphamide in experimental pyelonephritis in mice].
    Slavcheva E, Ivanova E, Georgiev D.
    Eksp Med Morfol; 1984 Sep; 23(4):186-95. PubMed ID: 6396063
    [No Abstract] [Full Text] [Related]

  • 14. Melatonin prevents neutrophil-mediated oxidative injury in Escherichia coli-induced pyelonephritis in rats.
    Sener G, Tuğtepe H, Velioğlu-Oğünç A, Cetinel S, Gedik N, Yeğen BC.
    J Pineal Res; 2006 Oct; 41(3):220-7. PubMed ID: 16948782
    [Abstract] [Full Text] [Related]

  • 15. Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis.
    Kaboré AF, Simard M, Bergeron MG.
    J Infect Dis; 1999 May; 179(5):1162-72. PubMed ID: 10191219
    [Abstract] [Full Text] [Related]

  • 16. [Immunity during ampicillin administration against a background of immunosuppression].
    Sakaeva DD, Lazareva DN.
    Eksp Klin Farmakol; 1998 May; 61(6):39-41. PubMed ID: 9929815
    [Abstract] [Full Text] [Related]

  • 17. Immunological aspects of chronic pyelonephritis. Cellular immune response in chronic pyelonephritis.
    Szabó T, Fekete B, Petrányi G.
    Acta Med Acad Sci Hung; 1974 May; 31(3-4):211-8. PubMed ID: 4620050
    [No Abstract] [Full Text] [Related]

  • 18. Cellular basis of host defence in pyelonephritis. I. Chronic infection.
    Miller TE, Findon G, Cawley S.
    Br J Exp Pathol; 1986 Feb; 67(1):13-23. PubMed ID: 3511938
    [Abstract] [Full Text] [Related]

  • 19. [The experimental studies of anticorporeal administration of azathioprine].
    Brinkmeyer B, Loew H, Ritzerfeld W.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):408-14. PubMed ID: 4935848
    [No Abstract] [Full Text] [Related]

  • 20. Immunology of pyelonephritis. III. Effect of colloidal carbon.
    Angel JA, Roberts JA, Smith TW, Di Luzio NR.
    J Urol; 1982 Sep; 128(3):624-8. PubMed ID: 6750151
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.